EDGE CMT: Predicting bacteriophage susceptibility from Escherichia coli genotype
EDGE CMT: Predicting bacteriophage susceptibility from Escherichia coli genotype
批准号:
2220735
负责人:
Adam Arkin
金额:
$205.52万
依托单位国家:
美国
项目类别:
Continuing Grant
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-10-01 至 2026-09-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This award to the University of California-Berkeley is made to support investigations of host-pathogen interactions using bacteria and phage as a tractable experimental system. The bacterial virome, the collection of viruses that parasitize the microbes, is a critical feature of microbial community dynamics, activity and adaptation. As part of these community dynamic, bacterial viruses (bacteriophage or phages) attack exceptionally specific bacterial hosts, much like other viruses infect only very-specific plants or animals. However, the mechanisms underlying this specificity are deeply under-characterized and studies have largely focused on a handful of individual bacterium-phage systems. The lack of insights into phage specificity and the breadth of bacterial responses to different phages has limited our ability to build models that can predict which phages have the potential to infect specific bacterial strains. Research supported by this award will help to fill this knowledge gap for an environmentally and medically important species of bacteria and its phage by exploiting an extensive collection of thousands of non-model Escherichia coli (e. coli) strains originating from hundreds of environmental and animal reservoirs. The researchers will use a correspondingly diverse collection of phages alongside high-throughput genetics and measurement to map the susceptibility of these bacteria to infection and create models to predict, given the genome of a new strain of E. coli, which phage might be most effective at targeting it. Graduate students and postdoctoral trainees from under-represented groups will be supported by this award, and the researchers will use data from these studies for data science training efforts available to larger groups. Results of this effort may eventually lead to effective bio-control options to manage bacterial populations, potentially reducing the need for antimicrobial use in a wide range of application areas including agriculture, sanitation, industrial processes, and biomedical environments.Since their discovery 100 years ago, our knowledge of phage abundance, diversity, modes of infectivity and their contribution to horizontal gene transfer, microbiome structure and functional traits is limited to few environmental contexts and individual bacterium-phage systems. Research supported by this award will create a machine-learning-driven experimental workflow that exploits a natural genetic variation in bacterial strains and associated phages, scalable susceptibility assays and high throughput genetics to create a predictive model connecting bacterial genotype to phage susceptibility phenotype. The researchers will leverage an extensive collection of non-model e. coli strains originating from hundreds of reservoirs and geographic locations representative of agricultural, medical and environmentally important species. The researchers will employ high-throughput genomics and genetics to gain a mechanistic understanding of thousands of phage-host interactions necessary to build predictive models linking bacterial genotype to phage susceptibility phenotype. The success of this project will advance our understanding of complex susceptibility phenotypes and could enable development of rational phage-cocktail formulations to treat drug resistance infections, implement biocontrol measures and enable precision microbiome engineering applications. The results of the studies will be presented at scientific meetings and published in peer-reviewed journals.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
RCN-UBE Incubator: KBase Educators: Microbiome Workforce Development Program
-
批准号:2316244
-
项目类别:Standard Grant
-
资助金额:$7.5万
-
财政年份:2023
-
负责人:Adam Arkin
-
依托单位:
Collaborative Research - Biochemically-Constrained Genomic Signal Processing (BioGSP): A Multi-Scale Interdisciplinary Approach to Regulatory Network Inference
-
批准号:0850205
-
项目类别:Continuing Grant
-
资助金额:$12.74万
-
财政年份:2009
-
负责人:Adam Arkin
-
依托单位:
SynBERC BioFAB Facility
-
批准号:0946510
-
项目类别:Standard Grant
-
资助金额:$140.0万
-
财政年份:2009
-
负责人:Adam Arkin
-
依托单位:
Engineering Eukaryotic Protein Scaffolds to Reprogram Prokaryotic Signaling and Metabolic Pathways
-
批准号:0756801
-
项目类别:Standard Grant
-
资助金额:$54.0万
-
财政年份:2008
-
负责人:Adam Arkin
-
依托单位:
国内基金
海外基金
登录
查看更多内容
KIF1B基因突变致CMT2A临床异质性的分子机制及靶向剪接修复策略研究
-
批准号:JCZRLH202600936
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
CMT2F上调PD-L1介导肥胖对肿瘤免疫微环境的作用与机制研究
-
批准号:2025JJ60587
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:向敏敏
-
依托单位:
GARS/WARS突变干扰核糖体翻译调控在CMT发病机制中的研究
-
批准号:2025JJ60567
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:谢雍之
-
依托单位:
四环素 CMT3 荷载多功能寡核苷酸 AS1411 治疗牙周炎及其机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:
-
依托单位:
SORD-CMT2轴索变性的分子机制和靶向治疗研究
-
批准号:82171172
-
项目类别:面上项目
-
资助金额:55万元
-
批准年份:2021
-
负责人:张如旭
-
依托单位:
CMT致病新基因C1orf194通过钙代谢失调引起轴突变性的作用机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:58万元
-
批准年份:2021
-
负责人:熊符
-
依托单位:
海洋超厚构件大功率摆动激光诱导CMT电弧超窄间隙焊接工艺及过程调控
-
批准号:U21A20129
-
项目类别:--
-
资助金额:260万元
-
批准年份:2021
-
负责人:秦国梁
-
依托单位:
MFN2基因突变导致CMT2A轴索内线粒体分布异常及其发病的机制
-
批准号:82001349
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:吴锐
-
依托单位:
镁合金CMT摆动电弧熔敷增材+FSP复合制造成形机理研究
-
批准号:52075377
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:申俊琦
-
依托单位:
通过内质网-线粒体结构偶联为靶标筛选2A型腓骨肌萎缩症(CMT2A) 疾病神经退行的抑制药物
-
批准号:2020A151501940
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2020
-
负责人:包飞翔
-
依托单位: